GEN-MKT-18-7897-A
Mar 18, 2019 | Blogs, Forensic | 0 comments
There just isn’t a screening approach available that can give us everything we need when throughput is the priority.
Sound familiar? For many toxicology labs, there is a misconception that compromises need to be made when it comes to high throughput drug screening. True, this certainly has been the case in the past, but things are changing.
Technology is advancing like never before, and this has the potential to revolutionize the forensics field. In the coming years, the beginnings of this revolution may arrive in the form of a fast technique that can detect an unlimited number of analytes with mass accuracy. We are here to tell you that such a technique could be available sooner than you would expect.
The 5 Demands of Forensic ToxicologistsWhy settle for a method that doesn’t meet your every demand? At SCIEX, making compromises doesn’t rest easy with us, and so we got to work on developing a faster screening method that meets the five demands of the high-throughput forensic lab:
Now you can say goodbye to techniques that are slow and inflexible to adapt to new analytes, lack specificities and often require multiple individual tests to complete the entire panel of targeted compounds if your method uses LC-MS/MS with a typical LC run time of more than 5 minutes…adios to this as well.
The Ultra-Fast Method That Meets ThemThe team at SCIEX has developed an ultra-fast forensic toxicological screening method with an LC runtime of 2.5 minutes.
In the SCIEX Forensics Compendium 2018, we present the tech note: Ultra-Fast Forensic Toxicological Screening and Quantitation in Under 3 Minutes Using SCIEX X500R QTOF System and SCIEX OS 1.0 Software.
This ultra-fast forensic toxicological screening method has been developed specifically to address the five demands listed above. Using the SCIEX X500R LC-MS/MS system with SCIEX OS Software 1.0, you benefit from mass accuracy, LC retention times and MS/MS spectral library matching. This technology is a great fit for forensic drug screening because the data provides structural information for every possible analyte. Scanning across the full mass range offers the fine spectral details of the precursor ions on the analytes, as well as the product ions in very high resolving power.
In the study, we also compare two non-targeted data acquisition methods: IDA-MS/MS and MS/MSALL with SWATH® Acquisition. Which of these approaches win, or maybe it’s not as clear cut as that? Read the tech note to find out.
Download the Compendium to see this method in its full glory, along with recent advancements developed by the forensics team and a view on where LC-MS/MS technology could take forensics in the future.
It is no secret that (bio)pharmaceutical research and development is complex, both scientific and regulatory processes. Here is an overview of just some of the ways SCIEX is working to support these challenges.
In a recent webinar, available on demand, scientists Luiza Chrojan and Ryan Hylands from Pharmaron, provided insights into the deployment of capillary gel electrophoresis (CGE) within cell and gene therapy. Luiza and Ryan shared purity data on plasmids used for adeno-associated virus (AAV) manufacturing and data on AAV genome integrity, viral protein (VP) purity and VP ratios using the BioPhase 8800 system.
Last year, Technology Networks hosted two webinars that featured groundbreaking research utilizing SWATH DIA (data-independent acquisition) for exposomics and metabolomics. Researchers Dr. Vinicius Verri Hernandes from the University of Vienna and Dr. Cristina Balcells from Imperial College London (ICL) demonstrated how a DIA approach can be successfully implemented in small molecule analysis using the ZenoTOF 7600 system. Their innovative approaches highlight the potential of SWATH DIA to enhance the detection and analysis of chemical exposures and metabolites, paving the way for new insights into environmental health and disease mechanisms.
Posted by
You must be logged in to post a comment.
Share this post with your network